PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of Temozolomide Capsules, USP to the portfolio.
Temozolomide Capsules, USP is an alkylating drug indicated for the treatment of adults with:
• Newly diagnosed glioblastoma concomitantly with radiotherapy and then as maintenance treatment
• Anaplastic astrocytoma
• Adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma
• Treatment of adults with refractory anaplastic astrocytoma
Temozolomide Capsules, USP are available in the following strengths and sizes:
To find out more information on Temozolomide Capsules, USP, please visit: www.camberpharma.com/temozolomide
